Rapidly Progressive IgA Nephropathy: A Case Report With Review of Clinical Presentation, Prognostic Factors and Therapeutic Modalities

Isaac Akkad, Alberto Ortiz, Melvyn Hecht

Abstract


IgA nephropathy (IgAN) is the most common glomerulonephritis in the Western world. Generally, the diagnosis of IgAN is based on clinical history, laboratory data, and histopathological reports. The rapidly progressing and crescentic subtype is quite uncommon. The clinical picture and spectrum of severity upon presentation varies between individual cases. In this case report, we present a previously healthy 20-year-old Latin American male with anti-neutrophil cytoplasmic antibodies seropositive rapidly progressing IgAN leading to severe acute renal impairment, uremic pericarditis, and uremic encephalopathy. Prognostic markers and histopathological types of injury have been proposed as tools to assess severity of disease and in guiding therapeutic options. This case report highlights histopathological, serological, and clinical characteristics of severe IgAN.




J Med Cases. 2016;7(6):230-233
doi: http://dx.doi.org/10.14740/jmc2498w


Keywords


Anti-neutrophil cytoplasmic antibodies; Rapidly progressive glomerulonephritis; Oxford classification; Absolute renal risk score

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.